European Society Of Cardiology

The study, presented at the European Society of Cardiology meeting, analyzed data from 90,903 UK Biobank participants and found that compensatory sleep significantly benefits heart health, especially for the sleep-deprived.

According to new research led by the European Society of Cardiology, a six-month exercise programme helps maintain normal heart rhythm and reduces the severity of symptoms in patients with atrial fibrillation.

Love coffee? Here's another reason to rejoice and raise your cupful of steaming brew.

Heart failure among people who are aged above 60 is set to triple by 2060, a new study has found.

We've got some excellent news for tea drinkers! According to a study presented at the European Society of Cardiology (ESC), drinking tea can reduce the risk of dying early from causes unrelated to the heart by almost 24 per cent. (More: Why drinking tea...

So far the experimental system has only been tested on pigs hearts, which were successfully regulated.

The Swiss drugmaker impressed doctors at the European Society of Cardiology meeting in Barcelona at the weekend by unveiling strikingly good clinical trial results for the drug, known as LCZ696, in a keenly awaited clinical trial.

The study, presented at the European Society of Cardiology meeting, analyzed data from 90,903 UK Biobank participants and found that compensatory sleep significantly benefits heart health, especially for the sleep-deprived.

According to new research led by the European Society of Cardiology, a six-month exercise programme helps maintain normal heart rhythm and reduces the severity of symptoms in patients with atrial fibrillation.

Love coffee? Here's another reason to rejoice and raise your cupful of steaming brew.

Heart failure among people who are aged above 60 is set to triple by 2060, a new study has found.

We've got some excellent news for tea drinkers! According to a study presented at the European Society of Cardiology (ESC), drinking tea can reduce the risk of dying early from causes unrelated to the heart by almost 24 per cent. (More: Why drinking tea...

So far the experimental system has only been tested on pigs hearts, which were successfully regulated.

The Swiss drugmaker impressed doctors at the European Society of Cardiology meeting in Barcelona at the weekend by unveiling strikingly good clinical trial results for the drug, known as LCZ696, in a keenly awaited clinical trial.